Related Experiment Video
Updated: Jun 28, 2026
08:41
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Published on: October 27, 2014
Direct stenting versus predilatation and stenting technique when using paclitaxel-eluting stents
Tolga Kocum1, Mustafa Yurtdas, Turkay Ozcan
1Department of Cardiology, Faculty of Medicine, Baskent University, Turkey.
International Heart Journal
|October 31, 2008
Summary
Direct stenting using paclitaxel-eluting stents is safe and feasible, reducing procedure and fluoroscopy times. This method shows no adverse effects on coronary angiography outcomes compared to traditional predilatation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Direct stenting without predilatation is established for bare metal stents.
- Evidence for direct stenting with drug-eluting stents is less extensive.
- Paclitaxel-eluting stents are commonly used in percutaneous coronary interventions.
Purpose of the Study:
- To evaluate the safety and feasibility of direct stenting with paclitaxel-eluting stents.
- To compare direct stenting versus conventional predilatation and stenting.
- To assess procedural efficiency and angiographic outcomes.
Main Methods:
- Retrospective analysis of 364 coronary lesions in 257 patients undergoing elective stenting.
- Comparison of direct stenting versus stenting with predilatation groups.
- Quantitative coronary angiography analysis at follow-up.
Main Results:
- Direct stenting significantly reduced procedure time (41.2 vs 32.1 min) and fluoroscopy time (15.5 vs 10.6 min).
- No significant difference in quantitative angiographic parameters, stent thrombosis, or restenosis rates between groups.
- All procedures were uneventful with no deaths during follow-up.
Conclusions:
- Direct stenting with paclitaxel-eluting stents is a feasible and safe alternative to conventional predilatation.
- The technique decreases procedural time and radiation exposure.
- No compromise in angiographic outcomes or safety is observed.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...